Premier Industrial Corporation Limited IPO

01At a glance

What the company does: makes powders, ferro-alloy, metal, chemical and mineral, and low-alloy, stainless-steel and nickel-alloy wires, which welding-consumable makers use to make electrodes and wires; the CRISIL report it cites says it offers the widest range of such powders among its peers and supplied about 8% of domestic demand for metal and ferro-alloy powders in FY25 (DRHP p.27). Its plants are in Maharashtra and Tamil Nadu (DRHP p.32).

Who pays it: welding-consumable manufacturers in India and abroad; the top ten customers were 40.44% of FY25 revenue (DRHP p.45). North America provided 13.59% of FY25 revenue and South-East Asia 9.61% (DRHP p.43).

Why it is raising money: ₹512.26 million for a new facility at Khalapur, Raigad, ₹589.61 million to expand the Wada unit, ₹670.00 million for working capital, and the rest for general purposes (DRHP p.28).

How fast it has grown: revenue of ₹3,706 million in FY23, ₹3,395 million in FY24 and ₹4,764 million in FY25 (DRHP p.30).

The one thing to understand: margins, not only volume, drove profit. EBITDA margin nearly doubled from 8.83% in FY23 to 16.93% in FY25 and profit quadrupled, but operating cash flow was negative ₹113.74 million in FY25 (DRHP p.43, DRHP p.148).

02The business, in plain words

A welding-materials supplier makes metal and mineral powders and welding wire to the specifications its customers need; the customers turn them into the electrodes and consumables used by fabricators and builders.

An electrode maker in South-East Asia needs a steady supply of ferro-manganese powder → it orders from Premier → Premier makes the powder at one of its plants → it ships the order and is paid on credit.

The main risk the document lists is the availability and cost of raw materials bought from third parties (DRHP p.32).

Earnings equation: Profit ≈ tonnes sold × (price − alloy and mineral cost − processing) − interest. EBITDA margin was 16.93% in FY25 (DRHP p.148).

03Where the money comes from

Source: DRHP p.43, DRHP p.45.

04The growth record

Source: DRHP p.30, DRHP p.43, DRHP p.148.

Return on capital employed was 14.31% in FY23, 21.01% in FY24 and 25.98% in FY25 (DRHP p.149). Trade receivable days were 81 in FY23, 80 in FY24 and 67 in FY25, and working capital cycle days 148, 172 and 158 (DRHP p.50).

05What the growth is made of

Exports and margin. Revenue from North America rose from ₹153.90 million in FY23 to ₹647.61 million in FY25 (DRHP p.43). EBITDA grew 146% over two years while revenue grew 29% (our arithmetic, DRHP p.148). The pages read do not explain the margin gain.

06Earnings quality

Profit of ₹974.63 million over FY23 to FY25 came with operating cash flow of ₹131.77 million (our arithmetic, DRHP p.30, DRHP p.43). The document lists negative operating cash flow among its top risks (DRHP p.32).

07The balance sheet

Source: DRHP p.30, DRHP p.31.

Share capital rose from ₹83.99 million to ₹799.61 million in FY25; the promoters' average acquisition cost is ₹0.46 to ₹0.77 a share (DRHP p.30, DRHP p.36).

08What the money is for

Source: DRHP p.28.

09Who is selling

Source: DRHP p.28, DRHP p.29. Together they offer up to 5,400,000 shares (DRHP p.27).

The company issues up to 22,500,000 new shares (DRHP p.27). The offer for sale is up to 2,170,800 shares by Arvind Chhotalal Morzaria, up to 1,740,030 by Dilip Chhotalal Morzaria, up to 1,078,770 by Subhash Chhotalal Morzaria, up to 341,895 by Lalit Navinchandra Morzaria and up to 68,505 by Nirmala Navinchandra Morzaria (DRHP p.3).

10Promoters

The promoters are Arvind Chhotalal Morzaria, Dilip Chhotalal Morzaria, Subhash Chhotalal Morzaria, Lalit Navinchandra Morzaria, Smeet Morzaria, Meet Arvind Morzaria and Anand Dilip Morzaria (DRHP p.27). The promoters have one civil proceeding of their own involving ₹612.26 million, in addition to nine small tax matters against them (DRHP p.32). Remuneration paid to the seven promoters totalled ₹64.50 million in FY23 and ₹76.54 million in FY25 (our arithmetic, DRHP p.33).

11Who already owns it

Source: DRHP p.29. The Morzaria family holds 100% (DRHP p.29).

12What changed just before the IPO

• Share capital: increased nearly tenfold in FY25 (DRHP p.30).
• Exports: North America up to 13.59% of revenue (DRHP p.43).
• Cash: operating cash flow negative in FY25 (DRHP p.43).

The company made a bonus issue in the ratio of 852 shares for every 100 held on 9 December 2024 (DRHP p.99). M/s. Sudhir C Oltikar & Co resigned as statutory auditor on 8 August 2024 and S H B A & CO LLP was appointed on 16 August 2024 (DRHP p.90). The founders' partnership firm became a public limited company under a certificate of incorporation dated 8 August 2007 (DRHP p.3).

13Capacity and expansion

Plants in Maharashtra, including Wada, and Tamil Nadu (DRHP p.28, DRHP p.32). The proceeds fund a new facility at Khalapur and expansion at Wada (DRHP p.28).

14Market size and industry structure

The CRISIL report cited in the offer document estimates India's welding raw-material and consumables market at 490 to 545 thousand tonnes in FY2025 and projects 780 to 815 thousand tonnes by FY2030 (DRHP p.27). Those projections are CRISIL's, and newboard has not tested them.

15Competitive position

What the document claims, and what it rests on:

• Both powders and wires, which few players make, citing CRISIL (DRHP p.27).
• The widest powder range among peers, citing CRISIL (DRHP p.27).

Against that: raw-material dependence, reliance on powder sales, export-policy risk and no long-term customer contracts (DRHP p.32, DRHP p.45).

16Peers the company named

The document gives the listed peers' P/E range as 28.40 to 43.82, average 36.25, using prices on 26 September 2025 (DRHP p.145). The peer names were not read for this study.

No P/E is possible for the company until a price band is set.

17Risks, in plain words

• Raw materials. Availability and price (DRHP p.32).
• Powders. Most revenue from one category (DRHP p.32).
• Exports. Policy changes in markets such as North America (DRHP p.32, DRHP p.43).
• Cash flow. Negative in FY25 (DRHP p.32).
• Expansion. Two projects to execute (DRHP p.32).

18Litigation and regulatory matters

Source: DRHP p.32.

19Related-party transactions

Not read in detail for this study.

20What the offer document does not say

In the sections read for this study, the document does not give:

• What the promoters' ₹612 million civil claim concerns, in the pages read.
• What drove the margin increase, in the pages read.
• Why operating cash flow turned negative in FY25, in the pages read.
• Capacity and utilisation figures, in the pages read.
• The price band, lot size or issue dates, which is normal at DRHP stage.

21Five questions for management

1. What made EBITDA margin rise from 9% to 17% in two years?
2. Who are the North American customers, and how exposed are they to trade-policy changes?
3. Why was operating cash flow negative in FY25?
4. What is the promoters' ₹612 million civil claim about, and against whom?
5. What will Khalapur make that Wada cannot?

1Sources and cited facts

This study was read from 1 document the company filed. The 60 figures it cites are listed under the document each came from, with the page and the sentence as printed.